It’s been a few years since we last spoke. Can you give our readers a refresher on the company and its history? Dr. Bedu-Addo: So, PDS Biotechnology is developing immunotherapies that train the immune ...

So it’s been a few years since we last spoke. Let’s start with a brief overview and history of the company. Mr. Itescu: Sure. So Mesoblast has been publicly listed both on Nasdaq and the Australian ...

Tell us about the current trends and themes that are most impacting the space, the subsectors, you watch? Dr. Phipps: Sure. My coverage spans a range of biopharma companies, including large-caps such ...

Recently you wrote a wonderful article that was published in Forbes magazine. In the context of an introduction to your coverage, what inspired you to write that piece, and what are some of the main ...

We’ve spoken several times before, but can you just give our readers a brief refresher on the company and how it has evolved over the years? Mr. Do: BioVie is a biotech company that started developing ...